Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Cessation and reduction in alcohol consumption and misuse after psychedelic use.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Journal of psychopharmacology (Oxford, England)
Date
2019-09-01
Source
PubMed
DOI
10.1177/0269881119845793
PubMed
31084460
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:25 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 15 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies2026-08-18Psychedelics for the Treatment of Substance Use Disorders2025-12-01Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience2025-11-20Beyond prohibition: A public health analysis of naturalistic psychedelic use2025-07-03Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review2025-05-02Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis2025-04-24Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey2025-04-22Moral Considerations and the Experience of Ego Dissolution: Insights from Psilocybin2025-01-01Assessing Metro Vancouver Residents’ Knowledge and Opinions of Psilocybin2023-10-12Expectancies for Subjective and Antidepressant Effects in Psilocybin Users2023-09-22Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects2022-12-01Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current research2022-06-22Counselors’ attitudes toward psychedelics and their use in therapy2022-03-19New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances2021-09-17Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy2020-11-10

Related papers

No close related records were found yet.